CATX R&D Expense Growth
Perspective Therapeutics Inc · R&D Expense Growth
CATX R&D Expense Growth
Latest reported114.11%period ending
CATX FY R&D Growth (YoY) (0.00% → 114.11%)
Latest values, visible window
High-resolution chart · PNG
CATX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 114.1132% | |
| 84.562% | |
| 1,075.455% | |
| -29.7831% | |
| 80.939% | |
| 26.7318% | |
| -23.6092% | |
| -15.5785% | |
| 80.9326% | |
| 82.7482% | |
| -14.1064% | |
| -8.0789% | |
| 6.6489% | |
| -14.163% | |
| 57.0013% | |
| 36.4777% | |
| -64.434% | |
| -29.41% | |
| 0.9599% | |
| 198.6431% | |
| 227.5056% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |